Production (Stage)
Oaktree Acquisition Corp. III Life Sciences
OACC
$10.53
$0.0150.14%
NASDAQ
| 03/31/2025 | 09/30/2024 | 07/15/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 444.80K | 48.10K | -- | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 444.80K | 48.10K | -- | ||
| Operating Income | -444.80K | -48.10K | -- | ||
| Income Before Tax | 1.66M | -48.10K | -- | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | 1.66M | -48.10K | -- | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | 1.66M | -48.10K | -- | ||
| EBIT | -444.80K | -48.10K | -- | ||
| EBITDA | -- | -- | -- | ||
| EPS Basic | 0.07 | -0.01 | 0.00 | ||
| Normalized Basic EPS | 0.04 | -0.01 | 0.00 | ||
| EPS Diluted | 0.07 | -0.01 | 0.00 | ||
| Normalized Diluted EPS | 0.04 | -0.01 | 0.00 | ||
| Average Basic Shares Outstanding | 24.58M | 4.38M | -- | ||
| Average Diluted Shares Outstanding | 24.58M | 4.38M | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||